实用医学杂志
實用醫學雜誌
실용의학잡지
THE JOURNAL OF PRACTICAL MEDICINE
2014年
9期
1366-1369
,共4页
肝硬化%扶正化瘀方%四氯化碳%大鼠%α-平滑肌肌动蛋白
肝硬化%扶正化瘀方%四氯化碳%大鼠%α-平滑肌肌動蛋白
간경화%부정화어방%사록화탄%대서%α-평활기기동단백
Liver cirrhosis%Fuzheng Huayu decoction%Carbon tetrachloride%Rats%α-SMA
目的:评价扶正化瘀方对不同病理阶段四氯化碳(CCl4)大鼠肝纤维化及活化星状细胞的影响。方法:用CCl4复合法制备大鼠肝纤维化模型,干预组分别于造模之日、2周末、4周末起以扶正化瘀方稀释液灌胃,在第2、4、6周末分批处死大鼠,观察各组大鼠肝组织病理学,采用计算机图像分析测定大鼠肝组织纤维化面积比例;测定α-平滑肌肌动蛋白(α-SMA)的积分光密度(IOD)值。组间数据比较用完全随机设计的单因素方差分析。结果:随着造模时间的延长,与正常组比较,2、4、6周末模型组、各干预组肝组织纤维化面积比例明显升高,α-SMA表达亦均有升高(P<0.05);与模型组比较,各干预组大鼠肝组织纤维化面积比例均减少,大鼠肝组织α-SMA的表达均有下调,且均为药物干预一组下降显著(P<0.05)。结论:扶正化瘀方在不同病理阶段均减少了α-SMA的表达,具有抗肝纤维化的作用,且越早进行干预治疗效果越好。
目的:評價扶正化瘀方對不同病理階段四氯化碳(CCl4)大鼠肝纖維化及活化星狀細胞的影響。方法:用CCl4複閤法製備大鼠肝纖維化模型,榦預組分彆于造模之日、2週末、4週末起以扶正化瘀方稀釋液灌胃,在第2、4、6週末分批處死大鼠,觀察各組大鼠肝組織病理學,採用計算機圖像分析測定大鼠肝組織纖維化麵積比例;測定α-平滑肌肌動蛋白(α-SMA)的積分光密度(IOD)值。組間數據比較用完全隨機設計的單因素方差分析。結果:隨著造模時間的延長,與正常組比較,2、4、6週末模型組、各榦預組肝組織纖維化麵積比例明顯升高,α-SMA錶達亦均有升高(P<0.05);與模型組比較,各榦預組大鼠肝組織纖維化麵積比例均減少,大鼠肝組織α-SMA的錶達均有下調,且均為藥物榦預一組下降顯著(P<0.05)。結論:扶正化瘀方在不同病理階段均減少瞭α-SMA的錶達,具有抗肝纖維化的作用,且越早進行榦預治療效果越好。
목적:평개부정화어방대불동병리계단사록화탄(CCl4)대서간섬유화급활화성상세포적영향。방법:용CCl4복합법제비대서간섬유화모형,간예조분별우조모지일、2주말、4주말기이부정화어방희석액관위,재제2、4、6주말분비처사대서,관찰각조대서간조직병이학,채용계산궤도상분석측정대서간조직섬유화면적비례;측정α-평활기기동단백(α-SMA)적적분광밀도(IOD)치。조간수거비교용완전수궤설계적단인소방차분석。결과:수착조모시간적연장,여정상조비교,2、4、6주말모형조、각간예조간조직섬유화면적비례명현승고,α-SMA표체역균유승고(P<0.05);여모형조비교,각간예조대서간조직섬유화면적비례균감소,대서간조직α-SMA적표체균유하조,차균위약물간예일조하강현저(P<0.05)。결론:부정화어방재불동병리계단균감소료α-SMA적표체,구유항간섬유화적작용,차월조진행간예치료효과월호。
Objective To evaluate the influence of Fuzheng Huayu decoction on different pathological stages fibrotic liver tissue and activated hepatic stellate cells (HSCs). Methods Use a carbon tetrachloride (CCl4)-induced liver cirrhosis rat model system. The drug intervention was administered via oral-gastric irrigation in building, the end of week 2 and 4. Rats were batch sacrificed at the end of week 2 , 4, and 6. Liver fibrosis was evaluated by histology, and expression of a-smooth muscle actin (α-SMA) was determined by immunohistochemistry. Between-group comparisons were made by completely random design and ANOVA with Bonferroni correction. Results At the end of weeks 2, 4 and 6, the model group and drug intervention groups had significantly higher area ratio of liver fibrosis and higher expression of α-SMA than the normal group, but the three drug intervention groups had significantly less area ratio of liver fibrosis and less expression of α-SMA than the model group and the drug intervention 1 group showed the most robust decrease (P<0.05). Conclusion The Fuzheng Huayu decoction leads to down-regulated α-SMA expression and reduced degree of liver fibrosis on different pathological stages of fibrotic liver tissue, and the earlier drug intervention, the better the results.